Differential localization of flavin-containing monooxygenase (FMO) isoforms 1, 3, and 4 in rat liver and kidney and evidence for expression of FMO4 in mouse, rat, and human liver and kidney microsomes

Journal of Pharmacology and Experimental Therapeutics

Volumn 329, Issue 3, 2009, Pages 1148-1155

  Novick, Rachel M ^a,b   Mitzey, Ann M ^a   Brownfield, Mark S ^a   Elfarra, Adnan A ^a,b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYLANILINE MONOOXYGENASE; DIMETHYLANILINE MONOOXYGENASE 1; DIMETHYLANILINE MONOOXYGENASE 3; DIMETHYLANILINE MONOOXYGENASE 4; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; ENZYME LOCALIZATION; GLOMERULUS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; KIDNEY COLLECTING TUBULE; KIDNEY DISTAL TUBULE; KIDNEY MEDULLA; KIDNEY MICROSOME; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE EPITHELIUM; LIVER MICROSOME; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE DISTRIBUTION; WESTERN BLOTTING;

ANIMALS; ANTIBODIES; ANTIBODY SPECIFICITY; CROSS REACTIONS; FEMALE; GOLGI APPARATUS; HUMANS; KIDNEY; KIDNEY CORTEX; KIDNEY GLOMERULUS; KIDNEY MEDULLA; KIDNEY TUBULES; LIVER; MALE; MICE; MICE, INBRED STRAINS; MICROSOMES; OXYGENASES; PROTEIN ISOFORMS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 66749114484     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.109.152058     Document Type: Article

References (39)

1. Bhamre S, Shankar SK, Bhagwat SV, and Ravindranath V (1993) Catalytic activity and immunohistochemical localization of flavin-containing monooxygenase in rat kidney. Life Sci 52:1601-1607. (Pubitemid 23114461)
2. Bühler R, Lindros KO, Nordling A, Johansson I, and Ingelman-Sundberg M (1992) Zonation of cytochrome P450 isozyme expression and induction in rat liver. Eur J Biochem 204:407-412.
3. Burnett VL, Lawton MP, and Philpot RM (1994) Cloning and sequencing of flavin-containing monooxygenases FMO3 and FMO4 from rabbit and characterization of FMO3. J Biol Chem 269:14314-14322. (Pubitemid 24191196)
4. Cashman JR and Zhang J (2006) Human flavin-containing monooxygenases. Annu Rev Pharmacol Toxicol 46:65-100. (Pubitemid 43271184)
5. Celius T, Roblin S, Harper PA, Matthews J, Boutros PC, Pohjanvirta R, and Okey AB (2008) Aryl hydrocarbon receptor-dependent induction of flavin-containing monooxygenase mRNAs in mouse liver. Drug Metab Dispos 36:2499-2505.
6. Chung WG, Park CS, Roh HK, and Cha YN (1997) Induction of flavin-containing monooxygenase (FMO1) by a polycyclic aromatic hydrocarbon, 3-methylcholanthrene, in rat liver. Mol Cells 7:738-741. (Pubitemid 127486197)
7. Cummings BS, Zangar RC, Novak RF, and Lash LH (1999) Cellular distribution of cytochromes P-450 in the rat kidney. Drug Metab Dispos 27:542-548. (Pubitemid 29177649)
8. Dolphin CT, Cullingford TE, Shephard EA, Smith RL, and Phillips IR (1996) Differential developmental and tissue-specific regulation of expression of the genes encoding three members of the flavin-containing monooxygenase family of man, FMO1, FMO3 and FM04. Eur J Biochem 235:683-689. (Pubitemid 26060969)
9. Falls JG, Blake BL, Cao Y, Levi PE, and Hodgson E (1995) Gender differences in hepatic expression of flavin-containing monooxygenase isoforms (FMO1, FMO3, and FMO5) in mice. J Biochem Toxicol 10:171-177.
10. Falls JG, Ryu DY, Cao Y, Levi PE, and Hodgson E (1997) Regulation of mouse liver flavin-containing monooxygenases 1 and 3 by sex steroids. Arch Biochem Biophys 342:212-223. (Pubitemid 27251241)
11. Hines RN, Cashman JR, Philpot RM, Williams DE, and Ziegler DM (1994) The mammalian flavin-containing monooxygenases: molecular characterization and regulation of expression. Toxicol Appl Pharmacol 125:1-6. (Pubitemid 24104447)
12. Itagaki K, Carver GT, and Philpot RM (1996) Expression and characterization of a modified flavin-containing monooxygenase 4 from humans. J Biol Chem 271:20102-20107. (Pubitemid 26281762)
13. Janmohamed A, Hernandez D, Phillips IR, and Shephard EA (2004) Cell-, tissue-, sex- and developmental stage-specific expression of mouse flavin-containing monooxygenases (fmos). Biochem Pharmacol 68:73-83. (Pubitemid 38746543)
14. Jones TW, Qin C, Schaeffer VH, and Stevens JL (1988) Immunohistochemical localization of glutamine transaminase K, a rat kidney cysteine conjugate β-lyase, and the relationship to the segment specificity of cysteine conjugate nephrotoxicity. Mol Pharmacol 34:621-627. (Pubitemid 19007298)
15. Krause RJ, Lash LH, and Elfarra AA (2003) Human kidney flavin-containing monooxygenases and their potential roles in cysteine s-conjugate metabolism and nephrotoxicity. J Pharmacol Exp Ther 304:185-191. (Pubitemid 36008927)
16. Krueger SK and Williams DE (2005) Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism. Pharmacol Ther 106:357-387.
17. Lash LH, Putt DA, Hueni SE, Krause RJ, and Elfarra AA (2003) Roles of necrosis, apoptosis, and mitochondrial dysfunction in S-(1,2-dichlorovinyl)-L- cysteine sulfoxide-induced cytotoxicity in primary cultures of human renal proximal tubular cells. J Pharmacol Exp Ther 305:1163-1172. (Pubitemid 36617995)
18. Lash LH, Sausen PJ, Duescher RJ, Cooley AJ, and Elfarra AA (1994) Roles of cysteine conjugate β-lyase and S-oxidase in nephrotoxicity: studies with S-(1,2-dichlorovinyl)-L-cysteine and S-(1,2-dichlorovinyl)-L-cysteine sulfoxide. J Pharmacol Exp Ther 269:374-383. (Pubitemid 24143277)
19. Lattard V, Buronfosse T, Lachuer J, Longin-Sauvageon C, Moulin C, and Benoit E (2001) Cloning, sequencing, tissue distribution, and heterologous expression of rat flavin-containing monooxygenase 3. Arch Biochem Biophys 391:30-40. (Pubitemid 32612570)
20. Lattard V, Lachuer J, Buronfosse T, Garnier F, and Benoit E (2002) Physiological factors affecting the expression of FMO1 and FMO3 in the rat liver and kidney. Biochem Pharmacol 63:1453-1464. (Pubitemid 34457960)
21. Lattard V, Longin-Sauvageon C, and Benoit E (2003) Cloning, sequencing and tissue distribution of rat flavin-containing monooxygenase 4: two different forms are produced by tissue-specific alternative splicing. Mol Pharmacol 63:253-261. (Pubitemid 36043829)
22. Lattard V, Zhang J, and Cashman JR (2004) Alternative processing events in human FMO genes. Mol Pharmacol 65:1517-1525. (Pubitemid 38668309)
23. Lawton MP, Cashman JR, Cresteil T, Dolphin CT, Elfarra AA, Hines RN, Hodgson E, Kimura T, Ozols J, and Phillips IR (1994) A nomenclature for the mammalian flavin-containing monooxygenase gene family based on amino acid sequence identities. Arch Biochem Biophys 308:254-257. (Pubitemid 24172630)
24. Lindros KO (1997) Zonation of cytochrome P450 expression, drug metabolism and toxicity in liver. Gen Pharmacol 28:191-196. (Pubitemid 27016124)
25. Lock EA and Reed CJ (1998) Xenobiotic metabolizing enzymes of the kidney. Toxicol Pathol 26:18-25. (Pubitemid 28100684)
26. Murray GI, McFadyen MC, Mitchell RT, Cheung YL, Kerr AC, and Melvin WT (1999) Cytochrome P450 CYP3A in human renal cell cancer. Br J Cancer 79:1836-1842. (Pubitemid 29132313)
27. Muskhelishvili L, Thompson PA, Kusewitt DF, Wang C, and Kadlubar FF (2001) In situ hybridization and immunohistochemical analysis of cytochrome P450 1B1 expression in human normal tissues. J Histochem Cytochem 49:229-236. (Pubitemid 32113385)
28. Nishimura M and Naito S (2006) Tissue-specific mRNA expression profiles of human phase I metabolizing enzymes except for cytochrome P450 and phase II metabolizing enzymes. Drug Metab Pharmacokinet 21:357-374.
29. Overby LH, Carver GC, and Philpot RM (1997) Quantitation and kinetic properties of hepatic microsomal and recombinant flavin-containing monooxygenases 3 and 5 from humans. Chem Biol Interact 106:29-45. (Pubitemid 27383438)
30. Rae JM, Johnson MD, Lippman ME, and Flockhart DA (2001) Rifampin is a selective, pleiotropic inducer of drug metabolism genes in human hepatocytes: studies with cDNA and oligonucleotide expression arrays. J Pharmacol Exp Ther 299:849-857. (Pubitemid 33104951)
31. Ripp SL, Overby LH, Philpot RM, and Elfarra AA (1997) Oxidation of cysteine S-conjugates by rabbit liver microsomes and cDNA-expressed flavin-containing mono-oxygenases: studies with S-(1,2-dichlorovinyl)-L- cysteine, S-(1,2,2-trichlorovinyl)-L-cysteine, S-allyl-L-cysteine, and S-benzyl-L-cysteine. Mol Pharmacol 51:507-515. (Pubitemid 27118488)
32. Ripp SL, Itagaki K, Philpot RM, and Elfarra AA (1999) Methionine S-oxidation in human and rabbit liver microsomes: evidence for a high-affinity methionine S-oxidase activity that is distinct from flavin-containing monooxygenase 3. Arch Biochem Biophys 367:322-332. (Pubitemid 29394182)
33. Rodriguez RJ and Acosta D Jr (1997) Metabolism of ketoconazole and deacetylated ketoconazole by rat hepatic microsomes and flavin-containing monooxygenases. Drug Metab Dispos 25:772-777. (Pubitemid 27259980)
34. Rodriguez RJ and Miranda CL (2000) Isoform specificity of N-deacetyl ketoconazole by human and rabbit flavin-containing monooxygenases. Drug Metab Dispos 28:1083-1086. (Pubitemid 30660364)
35. Sausen PJ and Elfarra AA (1990) Cysteine conjugate S-oxidase. Characterization of a novel enzymatic activity in rat hepatic and renal microsomes. J Biol Chem 265:6139-6145. (Pubitemid 20148152)
36. Stricker BH, Blok AP, Bronkhorst FB, Van Parys GE, and Desmet VJ (1986) Ketoconazole-associated hepatic injury. A clinicopathological study of 55 cases. J Hepatol 3:399-406. (Pubitemid 17227491)
37. Tijet N, Boutros PC, Moffat ID, Okey AB, Tuomisto J, and Pohjanvirta R (2006) Aryl hydrocarbon receptor regulates distinct dioxin-dependent and dioxin-independent gene batteries. Mol Pharmacol 69:140-153. (Pubitemid 43048901)
38. Zhang GH and Stevens JL (1989) Transport and activation of S-(1,2-dichlorovinyl)-L-cysteine and N-acetyl-S-(1,2-dichlorovinyl)-L-cysteine in rat kidney proximal tubules. Toxicol Appl Pharmacol 100:51-61. (Pubitemid 19209325)
39. Zhang J and Cashman JR (2006) Quantitative analysis of FMO gene mRNA levels in human tissues. Drug Metab Dispos 34:19-26. (Pubitemid 43042642)